Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Ann Biol Clin (Paris) ; 65(5): 555-62, 2007.
Article in French | MEDLINE | ID: mdl-17913676

ABSTRACT

The Unicel DXC 600 is an automated analytical system from Beckman Coulter for measuring usual biochemistry parameters (electrolytes, substrates and enzymatic activities), therapeutic drugs, drugs of abuse and specific proteins. According to the "Société française de biologie clinique (SFBC)" validation protocol, we tested the following parameters: electrolytes (sodium, potassium, chloride, total CO2), substrates (uric acid, calcium, phosphate, glucose, creatinine, urea, cholesterol, HDL cholesterol, bilirubin, iron, triglycerides), enzymes (ALAT, ASAT, amylase, CK, GGT, LDH, lipase, ALP), total proteins and specific proteins (albumin, CRP, haptoglobin). The results confirm the excellent analytical performances regarding imprecision. The comparison study shows differences between values obtained with Unicel DXC 600 and Integra 800 (Roche diagnostics), leading to the use of correcting factors for some parameters.


Subject(s)
Clinical Chemistry Tests/instrumentation , Blood Chemical Analysis/standards , Blood Proteins/analysis , Clinical Chemistry Tests/standards , Clinical Enzyme Tests/standards , Equipment Design , Humans , Proteinuria/urine , Reproducibility of Results , Time Factors , Urinalysis/standards
3.
Ann Biol Clin (Paris) ; 65(3): 299-302, 2007.
Article in French | MEDLINE | ID: mdl-17502304

ABSTRACT

Septicaemia concerning Lactobacillus jensenii is exceptional. This bacteria commensal of the normal human flora is known for its low pathogenicity. We report here the observation of a woman, 50 years old, who was admitted in our service for an obstructive acute renal failure and who has presented a septicaemia due to L. jensenii, with a favourable issue by use of antibiotics (amoxicillin-clavulanic acid). This observation permits to report the clinical and bacteriological characteristics of L. jensenii. The importance of the immunodepressed status (diabetes mellitus, chronic renal failure) and use of the endoureteral acts is mentioned.


Subject(s)
Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/microbiology , Lactobacillus , Sepsis/diagnosis , Sepsis/microbiology , Female , Gram-Positive Bacterial Infections/complications , Humans , Middle Aged
4.
Ann Biol Clin (Paris) ; 64(5): 501-5, 2006.
Article in French | MEDLINE | ID: mdl-17040884

ABSTRACT

Incidence of severe imported malaria increases with the multiplication of humanitarian and military missions in malarial endemic areas. The purpose of this study was to describe the demographic, clinical, therapeutic and outcome aspects of 9 cases which have been hospitalized in the intensive care unit and medecine service of the military hospital of Marrakech, between january 2001 and december 2004. Out of 68 patients admitted with symptomatic malaria during this period, 9 cases were considered as severe. All of them were male soldiers (mean age: 33,3 years), 7 of them have stayed in Democratic Republic of Congo, and 2 in Ivory Coast. Chemoprophylaxis consisted in chloroquine plus proguanil in 5 cases and mefloquine in 4 cases. The mean duration of stay in endemic area was 9,3 months. The clinical presentation was dominated by troubles of consciousness, which justified initial admission in the intensive care unit. The mean duration of hospitalization was 3,3 days in intensive care unit and 5,6 days in the medical department. Thick smear always revealed high parasitemia (5-15%) with Plasmodium falciparum, associated with Plasmodium ovale in two cases. Antimalarial treatment consisted in quinine salts administration. Evolution was favourable without recurrence in 7 cases, but 2 deaths were recorded. Severe imported malaria remains associated with bad outcome and requires early diagnosis and close monitoring of such cases.


Subject(s)
Malaria, Falciparum/epidemiology , Military Medicine , Adult , Antimalarials/therapeutic use , Chloroquine/therapeutic use , Cote d'Ivoire , Democratic Republic of the Congo , Hospitals, Military , Humans , Incidence , Intensive Care Units , Length of Stay , Malaria, Falciparum/diagnosis , Malaria, Falciparum/drug therapy , Malaria, Falciparum/mortality , Malaria, Falciparum/prevention & control , Male , Mefloquine/therapeutic use , Morocco/epidemiology , Proguanil/therapeutic use , Quinine/therapeutic use , Retrospective Studies , Treatment Outcome
5.
Sante ; 16(4): 259-62, 2006.
Article in French | MEDLINE | ID: mdl-17446159

ABSTRACT

Incidence of severe imported malaria increases with the multiplication of humanitarian and military missions in malarial endemic areas. The purpose of this study was to describe the demographic, clinical, therapeutic and outcome aspects of 9 cases which have been hospitalized in the intensive care unit and medecine service of the military hospital of Marrakech, between january 2001 and december 2004. Out of 68 patients admitted with symptomatic malaria during this period, 9 cases were considered as severe. All of them were male soldiers (mean age: 33,3 years), 7 of them have stayed in Democratic Republic of Congo, and 2 in Ivory Coast. Chemoprophylaxis consisted in chloroquine plus proguanil in 5 cases and mefloquine in 4 cases. The mean duration of stay in endemic area was 9,3 months. The clinical presentation was dominated by troubles of consciousness, which justified initial admission in the intensive care unit. The mean duration of hospitalization was 3,3 days in intensive care unit and 5,6 days in the medical department. Thick smear always revealed high parasitemia (5-15%) with Plasmodium falciparum, associated with Plasmodium ovale in two cases. Antimalarial treatment consisted in quinine salts administration. Evolution was favourable without recurrence in 7 cases, but 2 deaths were recorded. Severe imported malaria remains associated with bad outcome and requires early diagnosis and close monitoring of such cases.


Subject(s)
Malaria/diagnosis , Military Personnel , Adult , Animals , Antimalarials/therapeutic use , Cause of Death , Chemoprevention , Chloroquine/therapeutic use , Cote d'Ivoire , Critical Care , Democratic Republic of the Congo , Endemic Diseases , Hospitalization , Hospitals, Military , Humans , Length of Stay , Malaria/classification , Malaria, Falciparum/diagnosis , Male , Mefloquine/therapeutic use , Morocco , Plasmodium ovale/isolation & purification , Proguanil/therapeutic use , Quinine/therapeutic use , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL